Search - tctmd.com

Displaying 41 - 60 of 64

Sort: Relevancy | Date

Presentation THT 2023

Revivent TC® Procedure Planning and Anchor Placement Strategies

Presenter: Patrick Klein

March 21, 2023

Presentation THT 2023

Revivent TC® Patient Screening and Monitoring GDMT Response

Presenter: Michael Pfeiffer

March 21, 2023

Presentation THT 2023

The Revivent TC® Patient Phenotype

Presenter: Joggy George

March 21, 2023

Presentation THT 2023

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

First-in-Human and Early Feasibility Study of Transcatheter Left Ventricular Myocardial Injection of Alginate Hydrogel in Heart Failure Patients – the Deke XDROP System

Presenter: Scott Lim

March 21, 2023

Presentation THT 2023

Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients

Presenter: Boaz Manash

March 21, 2023

Presentation THT 2023

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Presenter: Oleg Polonetsky

March 21, 2023

Presentation THT 2023

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

Presenter: Tyler Bonkowski

March 21, 2023

Presentation THT 2023

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Presenter: Romy Hegeman

March 21, 2023

Presentation THT 2023

What Is the Potential Role of Shunts Across the Spectrum of LV EFs?

Presenter: Liviu Klein

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

Presentation THT 2023

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

Presenter: Mandeep Mehra

March 20, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

Presentation THT 2023

FDA Introduction

Presenter: Changfu Wu

March 20, 2023

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Presentation THT 2022

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Presenter: Sebastian Rosch

February 02, 2022

Presentation THT 2022

Left Ventricular Regional Functional Assessment for LIVE Therapy Using Inward Displacement

Presenter: Rishi Puri

February 02, 2022

Presentation THT 2022

Design and Rationale of the CORCINCH-HF pivotal study

Presenter: Ulrich Jorde

February 01, 2022

Advertisement

Revivent TC® Procedure Planning and Anchor Placement Strategies

Revivent TC® Patient Screening and Monitoring GDMT Response

The Revivent TC® Patient Phenotype

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

First-in-Human and Early Feasibility Study of Transcatheter Left Ventricular Myocardial Injection of Alginate Hydrogel in Heart Failure Patients – the Deke XDROP System

Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

What Is the Potential Role of Shunts Across the Spectrum of LV EFs?

TEER or VAD/Transplant in the Advanced HF Patient With MR?

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

FDA Introduction

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Hemodynamic Profiles Across the Range of Left Ventricular Ejection Fraction in Heart Failure With Preserved Ejection Fraction – Potential Therapeutic Implications

Left Ventricular Regional Functional Assessment for LIVE Therapy Using Inward Displacement

Design and Rationale of the CORCINCH-HF pivotal study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content